Writer, 30, 'looked pregnant' before surgeons removed a WATERMELON-sized tumour
Layla Cummins, of Bristol, visited her GP in January after feeling more bloated than normal. An ultrasound revealed a cyst on her ovary which was discovered to be 40cm in length when removed. (Source: the Mail online | Health)
Source: the Mail online | Health - April 17, 2019 Category: Consumer Health News Source Type: news

Niraparib Offers New Option in Heavily Pretreated Ovarian Cancer
Researchers conducted the QUADRA trial to examine if niraparib could improve outcomes in heavily pretreated patients with ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 17, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Don ’ t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown. (Source: NYT Health)
Source: NYT Health - April 16, 2019 Category: Consumer Health News Authors: HEATHER MURPHY Tags: Genetics and Heredity Tests (Medical) Breast Cancer DNA (Deoxyribonucleic Acid) Ovarian Cancer 23andMe Promethease (SNPedia) Invitae Corp. Source Type: news

Genetic Testing Under-Utilized in Ovarian Cancer Genetic Testing Under-Utilized in Ovarian Cancer
Only a minority of women with ovarian or breast cancer undergo recommended genetic testing, a new study suggests.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - April 15, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Metformin May Cut Risk for Prematurity, Miscarriage in PCOS
MONDAY, April 15, 2019 -- In pregnant women with polycystic ovary syndrome (PCOS), metformin treatment from the late first trimester until delivery might reduce the risk for late miscarriage and preterm birth but does not prevent gestational... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 15, 2019 Category: Pharmaceuticals Source Type: news

Loss of a DNA repair system creates a unique vulnerability in many cancer types
(Broad Institute of MIT and Harvard) Cancer cells adapt to potentially fatal mutations and other molecular malfunctions by adjusting one or more other genes' activity, in the process becoming dependent on those genes for their survival and growth. The resulting genetic dependencies may provide targets for developing new precision-guided drugs or other cancer treatment strategies.Reporting in Nature, researchers describe one such vulnerability shared by a large subset of colon, gastric, endometrial, and ovarian cancer cell lines. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 10, 2019 Category: Cancer & Oncology Source Type: news

Genetic Testing Underused in Breast, Ovarian Cancer
TUESDAY, April 9, 2019 -- Only one-quarter of those with breast cancer and one-third with ovarian cancer undergo genetic testing, according to a study published online April 9 in the Journal of Clinical Oncology. Allison W. Kurian, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2019 Category: Pharmaceuticals Source Type: news

Ovarian cancer patients undertested for mutations that could guide clinical care
(Stanford Medicine) Fewer than a quarter of breast cancer patients and a third of ovarian cancer patients diagnosed between 2013 and 2014 in two states underwent genetic testing for cancer-associated mutations, according to a study by researchers at the Stanford University School of Medicine and several other organizations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 9, 2019 Category: Cancer & Oncology Source Type: news

Teenager who thought her bloating was due to junk food was diagnosed with ovarian CANCER at 19
Seren Hughes, now 23, of Flintshire, had just started university when symptoms first appeared. But thinking she was simply run down, she upped her gym routine and cut back on unhealthy food. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2019 Category: Consumer Health News Source Type: news

Woman, 30, who went through the menopause aged 20 launches a desperate appeal to have her dream baby
Jade Burns, 30, of Essex, was devastated with a premature ovarian failure diagnosis. Her and her husband, Jon Burns, are no longer eligible for IVF in their area. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2019 Category: Consumer Health News Source Type: news

3 ways cinematic rendering helps visualize the spleen
Cinematic rendering allowed radiologists from Johns Hopkins University to uncover...Read more on AuntMinnie.comRelated Reading: Cinematic rendering makes strides in cancer evaluation Cinematic rendering paves way for 'virtual' physical exam Cinematic rendering enhances pelvic CT bone evaluation Cinematic rendering enhances ovarian cancer evaluation Cinematic rendering sheds light on abdominal pathology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 8, 2019 Category: Radiology Source Type: news

Ties: Great Eggspectations
Egg freezing had become so routine among my single peers that when I hit 35, I never thought twice. Here ’ s what I wish I had known. (Source: NYT Health)
Source: NYT Health - April 5, 2019 Category: Consumer Health News Authors: JASMIN ROSEMBERG Tags: Egg Donation and Freezing Women and Girls Ovaries Endometriosis Pregnancy and Childbirth Dating and Relationships Source Type: news

Study: The Pill May Protect Against Ovarian Cancer
After adjusting for such factors as age and whether women had ever given birth, any use of birth control pills was associated with a 46% lower risk of death within a year of an ovarian cancer diagnosis, the study found. (Source: WebMD Health)
Source: WebMD Health - April 3, 2019 Category: Consumer Health News Source Type: news

Cancer survivor who had an OVARY removed defies the odds to give birth to a healthy boy
Amy Smith-Morris, from Saskatoon in Canada, was diagnosed with ovarian cancer in 2016 after returning from her honeymoon but gave birth to her first child, Max, in March this year. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2019 Category: Consumer Health News Source Type: news

Birth Control Pills May Protect Against Most Serious Ovarian Cancer: Study
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 3, 2019 Category: Cancer & Oncology Tags: Gynecology, Obstetrics, Oncology, News, Source Type: news

Birth Control Pills May Protect Against Most Serious Ovarian Cancer: Study
WEDNESDAY, April 3, 2019 -- The protection that birth control pills offer against ovarian cancer is strongest with the most aggressive forms of the disease, a new study says. For several years, researchers have noted that women who have used oral... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 3, 2019 Category: General Medicine Source Type: news

Birth Control Pills May Protect Against Most Serious Ovarian Cancer: Study
Title: Birth Control Pills May Protect Against Most Serious Ovarian Cancer: StudyCategory: Health NewsCreated: 4/3/2019 12:00:00 AMLast Editorial Review: 4/3/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 3, 2019 Category: Cancer & Oncology Source Type: news

Birth Control Pills May Protect Against Most Serious Ovarian Cancer: Study
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - April 3, 2019 Category: Cancer & Oncology Source Type: news

New role for a driver of metastatic cancers
(Salk Institute) Metastatic ovarian, prostate and breast cancers are notoriously difficult to treat and often deadly. Now, Salk Institute researchers have revealed a new role for the CDK12 protein. The findings were published in the print version of Genes& Development on April 1, 2019. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 2, 2019 Category: Cancer & Oncology Source Type: news

Women Die From Heart Attacks More Often Than Men. Here ’s Why — and What Doctors Are Doing About It
Lilly Rocha was 37 years old in 2008 when she began having strange symptoms. When people asked her questions, she knew the answers but couldn’t articulate them. A tingling sensation on her left breast became painful. She thought she might have breast cancer, but her doctor assured her she was just experiencing stress from her demanding job. Her symptoms continued to get worse, and doctors continued to dismiss her. Three months later, at work, she became seriously ill. Luckily, her boss recognized the symptoms—chest and jaw pain and numbness in her left hand—and drove her to the nearest emergency room, whe...
Source: TIME: Health - April 1, 2019 Category: Consumer Health News Authors: Barbara Sadick Tags: Uncategorized heart health Source Type: news

Woman's infected ovarian cyst had traces of a VEGETABLE she had eaten in it
An unnamed mother from Rochester, Michigan, went to hospital with lower abdominal pain and doctors found she had a dermoid cyst which they described as 'very foul-smelling'. (Source: the Mail online | Health)
Source: the Mail online | Health - April 1, 2019 Category: Consumer Health News Source Type: news

Cinematic rendering makes strides in cancer evaluation
Cinematic rendering proved to be as accurate as conventional volume rendering...Read more on AuntMinnie.comRelated Reading: Cinematic rendering paves way for 'virtual' physical exam Cinematic rendering enhances pelvic CT bone evaluation Cinematic rendering enhances ovarian cancer evaluation Physicians prefer cinematic rendering for ankle injuries Cinematic rendering sheds light on abdominal pathology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 1, 2019 Category: Radiology Source Type: news

Niraparib not cost  effective for platinum-sensitive ovarian cancer
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Woman, 37, has FIVE 'miracle' babies after being told by doctors she 'would never conceive'
Cheryl Dodd, 37, of Shropshire, was diagnosed with polycystic ovary syndrome when she was 19. Told she could not have children, she considered adoption before conceiving. (Source: the Mail online | Health)
Source: the Mail online | Health - March 29, 2019 Category: Consumer Health News Source Type: news

Landmark Trial Halts Aggressive Surgery in Ovarian Cancer Landmark Trial Halts Aggressive Surgery in Ovarian Cancer
Maurie Markman discusses recent results from a phase 3 randomized trial of lymphadenectomy in advanced ovarian cancer.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 28, 2019 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Stand up to Cancer funded research to be presented March 30-April 3 at AACR Annual Meeting
(Stand Up To Cancer) Stand Up To Cancer supported research immunotherapy; organoids, precision therapies and cancer interception; pancreatic, breast, ovarian, lung, brain, colorectal, and pediatric cancers will be presented by SU2C-affiliated researchers including Nobel laureate James P Allison, PhD; Elizabeth Jaffee, MD, Crystal L. Mackall, MD, E John Wherry, PhD, Peter Dirks, MD, PhD, among others. SU2C SAC vice chair Raymond DuBois, MD to be honored. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 27, 2019 Category: Cancer & Oncology Source Type: news

Mother of two reveals she planned her wedding and funeral after being diagnosed with ovarian cancer 
EXCLUSIVE: Tina Potts, 40, from Wicklow Town, Ireland, has battled terminal cancer for 18 months. She married her partner of 13 years on Friday to 'make memories' for her two children. (Source: the Mail online | Health)
Source: the Mail online | Health - March 26, 2019 Category: Consumer Health News Source Type: news

Bringing endangered species back from the brink
(University of Oxford) A technique to produce eggs from ovarian tissue in the lab may offer hope for critically endangered species like the Northern White Rhino that have passed what is currently considered the point of no return. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 26, 2019 Category: International Medicine & Public Health Source Type: news

Surgery to Reduce Ovarian Cancer Risk — One Step or Two? Surgery to Reduce Ovarian Cancer Risk — One Step or Two?
Results from TUBA and WISP show high-risk women have few remaining cancer worries or decision regrets after undergoing prophylactic surgery to reduce ovarian cancer risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 26, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Racial Disparities in Hospice Enrollment Persist in Ovarian Cancer
In this study, researchers aimed to further characterize differences in hospice use in a cohort of ovarian cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - March 25, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Ovary function is preserved in transgender men at one year of testosterone therapy
(The Endocrine Society) Transgender men preserve their fertility potential even after one year of treatment with the male hormone testosterone, according to a study that will be presented Saturday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2019 Category: International Medicine & Public Health Source Type: news

Improved PCOS symptoms correlate with gut bacterial composition
(The Endocrine Society) Symptoms of polycystic ovary syndrome (PCOS) improved with exposure to healthy bacteria in the gut, according to a study in a mouse model of this common women's endocrine disorder. The study results will be presented Monday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2019 Category: International Medicine & Public Health Source Type: news

Niraparib Extends Time Without Symptoms in Ovarian Cancer
Findings based on phase 3 study of maintenance therapy with PARP inhibitor following treatment (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 22, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Conference News, Source Type: news

Novocure launches pivotal ovarian cancer trial
Novocure (NSDQ:NVCR) said today that it kicked off a Phase 3 pivotal trial testing its Tumor Treating Fields therapy combined with paclitaxel in people with recurrent, platinum-resistant ovarian cancer. The 540-patient trial has a primary endpoint of overall survival, with secondary endpoints that include progression-free survival, objective response rate, severity and frequency of adverse events and quality of life. Get the full story at our sister site, Drug Delivery Business News. The post Novocure launches pivotal ovarian cancer trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 22, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Featured Oncology Pharmaceuticals Wall Street Beat NovoCure Source Type: news

Niraparib Extends Time Without Symptoms in Ovarian Cancer
FRIDAY, March 22, 2019 -- Women with recurrent ovarian cancer who receive the poly ADP ribose polymerase (PARP) inhibitor niraparib as maintenance therapy after treatment have both more time without side effects and significantly longer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 22, 2019 Category: Pharmaceuticals Source Type: news

Nigeria: Talcum Powder May Cause Cancer, Experts Warn
[Guardian] Researchers are unanimous that talc or talcum powder can cause lung, ovarian, stomach and endometrial (uterine) cancers. They said talc consisting of asbestos is generally accepted as being able to cause cancer if it is inhaled or/and used regularly in the genital area. Evidence on asbestos-free talc is however less clear. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 22, 2019 Category: African Health Source Type: news

SGO 2019: TWiST Backs Benefits of PARP Inhibitor in Ovarian Cancer
The TWiST analysis of the phase III ENGOT-OV16/NOVA trial evaluated the time without symptoms or toxicity for niraparib vs placebo in patients with recurrent ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 21, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

SGO 2019: Maintenance Rucaparib Effective for All Age Groups in Ovarian Cancer, but Safety Questioned
The results of a post-hoc exploratory analysis of the phase III ARIEL3 trial were promising, but with some caveats. (Source: CancerNetwork)
Source: CancerNetwork - March 21, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

SGO 2019: Maintenance Rucaparib Effective for All Age Groups in Ovarian Cancer
The results of a post-hoc exploratory analysis of the phase III ARIEL3 trial were promising. (Source: CancerNetwork)
Source: CancerNetwork - March 21, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

Women's Wellness: Connect with women living with gynecologic cancer
Gynecologic cancers include?cervical cancer, endometriosis, fibroids,?ovarian cancer, pelvic masses,?uterine cancer,?vaginal cancer?and?vulvar cancer. Mayo Clinic Connect is a place where you can meet women living with a gynecologic cancer or caring for someone with gynecologic cancer. You can ask your questions, share your story, or just say hello. "Connect members find connection, support, and information from [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 21, 2019 Category: Databases & Libraries Source Type: news

Trials Test New Approach to Hereditary Ovarian Ca Risk Reduction
(MedPage Today) -- Preliminary data reports on symptoms, QOL with salpingectomy and delayed oophorectomy (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - March 20, 2019 Category: OBGYN Source Type: news

Vaccine Boosts OS in Late-Stage, Relapsed Ovarian Cancer
(MedPage Today) -- Survival at 2 years was 72.4% versus 40.9% with chemotherapy alone (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - March 20, 2019 Category: OBGYN Source Type: news

SGO 2019: Dendritic Cell –Based Immunotherapy Shows “Dramatic” Response for Ovarian Cancer
The phase II trial evaluated  dendritic cell–based immunotherapy with concomitant administration of chemotherapy vs chemotherapy alone. (Source: CancerNetwork)
Source: CancerNetwork - March 20, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

' End of the Road' for Trabectedin in Ovarian Cancer?
(MedPage Today) -- Trial stopped for futility, but 13-month OS improvement seen in patients with BRCA mutations (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 19, 2019 Category: Hematology Source Type: news

Mother, 38, claims she saw doctors over 20 TIMES before an ovarian cancer diagnosis
Claire Thompson visited her GP and A&E around 20 times over 18 months with severe heavy bleeding, She underwent a life-saving hysterectomy in 2016 when doctors discovered cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 19, 2019 Category: Consumer Health News Source Type: news

Lymphadenectomy in Advanced Ovarian Cancer: Will It Improve Survival?
A randomized trial tested whether lymphadenectomy would improve survival outcomes in patients with advanced ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 19, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

SGO 2019: Pembrolizumab Combo Shows Clinical Benefit for Recurrent Epithelial Ovarian Cancer
Results of a phase II trial evaluating pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide were presented at SGO 2019. (Source: CancerNetwork)
Source: CancerNetwork - March 19, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

New class of drugs could treat ovarian cancer
(University of Manchester) A team of researchers across the University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing. The Cancer Research UK and Wellcome Trust funded study, published in the journal Cancer Cell, showed that the drugs, called PARG inhibitors, can kill ovarian cancer cells by targeting weaknesses within their ability to copy their DNA. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2019 Category: Cancer & Oncology Source Type: news

When PARP Inhibitors Fail in Ovarian Cancer
(MedPage Today) -- Study identifies subgroup for whom another go could be worthwhile (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 18, 2019 Category: Hematology Source Type: news

TWiST Strengthens PARP Inhibitor Role in Ovarian Cancer TWiST Strengthens PARP Inhibitor Role in Ovarian Cancer
New analysis of the NOVA trial confirms clinical benefit from niraparib for patients with recurrent ovarian cancer. The benefit occurred both in patients with and in those without BRCA mutations.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news